101 related articles for article (PubMed ID: 2493723)
1. Long-term complications of conventional immunosuppressive treatment.
Boitard C; Bach JF
Adv Nephrol Necker Hosp; 1989; 18():335-54. PubMed ID: 2493723
[TBL] [Abstract][Full Text] [Related]
2. Drugs in autoimmune diseases.
Herrmann DB; Bicker U
Klin Wochenschr; 1990; 68 Suppl 21():15-25. PubMed ID: 2198387
[TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
4. Renal transplantation, immunosuppression and the skin: an update.
Moloney FJ; de Freitas D; Conlon PJ; Murphy GM
Photodermatol Photoimmunol Photomed; 2005 Feb; 21(1):1-8. PubMed ID: 15634217
[TBL] [Abstract][Full Text] [Related]
5. [Molecular mechanisms of action of some immunosuppressive drugs].
Liberman AC; Druker J; Refojo D; Arzt E
Medicina (B Aires); 2008; 68(6):455-64. PubMed ID: 19147430
[TBL] [Abstract][Full Text] [Related]
6. [Infections and immunosuppressive agents in rheumatology].
Kahn MF; Vitale C; Grimaldi A
Sem Hop; 1976 Jun 9-16; 52(22-23):1374-6. PubMed ID: 183273
[TBL] [Abstract][Full Text] [Related]
7. Treatment of corticoresistant idiopathic nephrotic syndrome in the adult: minimal change disease and focal segmental glomerulosclerosis.
Meyrier A; Simon P
Adv Nephrol Necker Hosp; 1988; 17():127-50. PubMed ID: 3124536
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive agents in dermatology.
Ho VC; Zloty DM
Dermatol Clin; 1993 Jan; 11(1):73-85. PubMed ID: 8435920
[TBL] [Abstract][Full Text] [Related]
9. [Immunosuppressive therapy in clinical practice].
Frey FJ
Schweiz Med Wochenschr; 1987 May; 117(21):810-5. PubMed ID: 3589636
[TBL] [Abstract][Full Text] [Related]
10. [Immunosuppression--a tightrope walk between iatrogenic harm and therapy].
Berchtold P; Seitz M
Schweiz Med Wochenschr; 1996 Sep; 126(38):1603-9. PubMed ID: 8927965
[TBL] [Abstract][Full Text] [Related]
11. Calcineurin inhibitors and rapamycin: cancer protection or promotion?
Weischer M; Röcken M; Berneburg M
Exp Dermatol; 2007 May; 16(5):385-93. PubMed ID: 17437481
[TBL] [Abstract][Full Text] [Related]
12. [Immunosuppressive treatment after organ transplantation].
Niaudet P
Arch Fr Pediatr; 1988; 45 Suppl 1():741-4. PubMed ID: 3240052
[TBL] [Abstract][Full Text] [Related]
13. [Immunosuppressive agents in organ transplantation].
Bergan S; Albrechtsen D; Bentdal O
Tidsskr Nor Laegeforen; 1999 Oct; 119(24):3615-20. PubMed ID: 10563181
[TBL] [Abstract][Full Text] [Related]
14. Anticancer Drug Development: The Way Forward.
Connors T
Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporin A: a powerful immunosuppressant.
Laupacis A; Keown PA; Ulan RA; McKenzie N; Stiller CR
Can Med Assoc J; 1982 May; 126(9):1041-6. PubMed ID: 7074504
[TBL] [Abstract][Full Text] [Related]
16. [Cancer in organ transplanted patients].
Pfeffer PF
Tidsskr Nor Laegeforen; 1999 Oct; 119(25):3792-4. PubMed ID: 10574060
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppression in organ transplantation.
Jordan SC; Rosenthal P; Makowka L
Semin Pediatr Surg; 1993 Nov; 2(4):206-7. PubMed ID: 8062042
[TBL] [Abstract][Full Text] [Related]
18. The newest medications in kidney transplantation and their mechanisms of action.
Lessan Pezeshki M
Urol J; 2004; 1(1):19-23. PubMed ID: 17874406
[TBL] [Abstract][Full Text] [Related]
19. Transplantation immunology: what the clinician needs to know for immunotherapy.
Rosen HR
Gastroenterology; 2008 May; 134(6):1789-801. PubMed ID: 18471555
[TBL] [Abstract][Full Text] [Related]
20. [Present and future of immunosuppressive therapy].
Eugui EM
Medicina (B Aires); 2000; 60(1):67-80. PubMed ID: 10835702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
